Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Probiotics improve renal function, glucose, lipids, inflammation and oxidative stress in diabetic kidney disease: a systematic review and meta-analysis
Yali Dai, JingJing Quan, Lianlian Xiong, et al.
Renal Failure (2022) Vol. 44, Iss. 1, pp. 862-880
Open Access | Times Cited: 70

Showing 1-25 of 70 citing articles:

Immunological mechanisms of inflammatory diseases caused by gut microbiota dysbiosis: A review
Min’an Zhao, Jiayi Chu, Shiyao Feng, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 114985-114985
Open Access | Times Cited: 115
Mitochondrial Glutathione in Cellular Redox Homeostasis and Disease Manifestation
Tsung‐Hsien Chen, Hsiang‐Chen Wang, Chia-Jung Chang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1314-1314
Open Access | Times Cited: 45
Recent advances in antimicrobial peptide-based therapy
Aditya Mulukutla, Romi Shreshtha, Vishal Kumar Deb, et al.
Bioorganic Chemistry (2024) Vol. 145, pp. 107151-107151
Closed Access | Times Cited: 21
Protective effect of berberine in diabetic nephropathy: A systematic review and meta-analysis revealing the mechanism of action
Shuangyuan Hu, Jundong Wang, Enmei Liu, et al.
Pharmacological Research (2022) Vol. 185, pp. 106481-106481
Closed Access | Times Cited: 43
The effect of microbiome-modulating probiotics, prebiotics and synbiotics on glucose homeostasis in type 2 diabetes: A systematic review, meta-analysis, and meta-regression of clinical trials
Pradipta Paul, Ridhima Kaul, Manale Harfouche, et al.
Pharmacological Research (2022) Vol. 185, pp. 106520-106520
Open Access | Times Cited: 39
A comprehensive review on the utilization of biopolymer hydrogels to encapsulate and protect probiotics in foods
Narmin Nezamdoost-Sani, Mohammad Alizadeh, Saber Amiri, et al.
International Journal of Biological Macromolecules (2023) Vol. 254, pp. 127907-127907
Closed Access | Times Cited: 30
An Updated View of the Effect of Probiotic Supplement on Sports Performance: A Detailed Review
Miray Nur Aykut, Esma Nur Erdoğan, Menşure Nur Çelik, et al.
Current Nutrition Reports (2024) Vol. 13, Iss. 2, pp. 251-263
Open Access | Times Cited: 9
Construction of a diagnostic model utilizing m7G regulatory factors for the characterization of diabetic nephropathy and the immune microenvironment
Jingying Zhong, Pengli Xu, Xuanyi Li, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Mechanisms of gut microbiota-immune-host interaction on glucose regulation in type 2 diabetes
Yu-Dian Zhou, Feng‐Xia Liang, Hao-Ran Tian, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 20
Clinical Perspectives of Gut Microbiota in Patients with Chronic Kidney Disease and End-Stage Kidney Disease: Where Do We Stand?
Alexandru Cosmin Pantazi, Mustafa Ali Kassim Kassim, Wassan Nori, et al.
Biomedicines (2023) Vol. 11, Iss. 9, pp. 2480-2480
Open Access | Times Cited: 20
Pathogenesis and therapy of radiation enteritis with gut microbiota
Qilin Yang, Bingzhi Qin, Weiliang Hou, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 17
Traditional Chinese medicine improved diabetic kidney disease through targeting gut microbiota
Xiaqing Wu, Lei Zhao, Yanlong Zhao, et al.
Pharmaceutical Biology (2024) Vol. 62, Iss. 1, pp. 423-435
Open Access | Times Cited: 6
Molecular mechanisms of gut microbiota in diabetic nephropathy
Gang Cheng, Yulin Liu, Rong Guo, et al.
Diabetes Research and Clinical Practice (2024) Vol. 213, pp. 111726-111726
Closed Access | Times Cited: 6
The role and mechanism of the gut microbiota in the development and treatment of diabetic kidney disease
Xiaofang Wu, Lei Zhao, Yújiāng Zhāng, et al.
Frontiers in Physiology (2023) Vol. 14
Open Access | Times Cited: 15
Effects of probiotics on non-alcoholic fatty liver disease: a review of human clinical trials
Chujin Cao, Mengxia Shi, Xiuru Wang, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 15
The role of probiotic supplementation in inflammatory biomarkers in adults: an umbrella meta-analysis of randomized controlled trials
Amir Hossein Faghfouri, Ladan Gol Mohammad Pour Afrakoti, Zeynab Kavyani, et al.
Inflammopharmacology (2023) Vol. 31, Iss. 5, pp. 2253-2268
Closed Access | Times Cited: 15
Hypomagnesemia as a Risk Factor and Accelerator for Vascular Aging in Diabetes Mellitus and Chronic Kidney Disease
Ákos Pethő, Mihály Tapolyai, Maria C. Browne, et al.
Metabolites (2023) Vol. 13, Iss. 2, pp. 306-306
Open Access | Times Cited: 14
Quantitative, Targeted Analysis of Gut Microbiota Derived Metabolites Provides Novel Biomarkers of Early Diabetic Kidney Disease in Type 2 Diabetes Mellitus Patients
Lavinia Balint, Carmen Socaciu, Andreea Iulia Socaciu, et al.
Biomolecules (2023) Vol. 13, Iss. 7, pp. 1086-1086
Open Access | Times Cited: 13
Inflammation and Oxidative Stress Induced by Obesity, Gestational Diabetes, and Preeclampsia in Pregnancy: Role of High-Density Lipoproteins as Vectors for Bioactive Compounds
Angélica Saraí Jiménez‐Osorio, Elizabeth Carreón‐Torres, Emmanuel Correa Solís, et al.
Antioxidants (2023) Vol. 12, Iss. 10, pp. 1894-1894
Open Access | Times Cited: 13
Effects of Probiotics on Markers of Oxidative/Nitrosative Stress and Damage Associated with Inflammation in Non-Communicable Diseases: a Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials
Natanny Swerts Silva, Cláudio Daniel Cerdeira, Tiago Marques dos Reis, et al.
Research Square (Research Square) (2025)
Closed Access
Skrining Probiotik Asal Produk Komersil yang Berpotensi Sebagai Inhibitor a-Glukosidase
Angelin Christin, Edy Fachrial
Ranah Research Journal of Multidisciplinary Research and Development (2025) Vol. 7, Iss. 2, pp. 1351-1363
Closed Access
The impact of probiotics therapy on cognitive and metabolic characteristics in patients with cognitive impairment: An umbrella review of meta-analysis of randomized controlled trials
Yaqin Chen, Yanchun Peng, Qi Niu, et al.
European Journal of Pharmacology (2025), pp. 177326-177326
Open Access
Microbiota and Inflammatory Markers: A Review of Their Interplay, Clinical Implications, and Metabolic Disorders
Emiliano Peña-Durán, Jesús Jonathan García-Galindo, Luis D. López-Murillo, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1773-1773
Open Access
The impact of probiotics on oxidative stress and inflammatory markers in patients with diabetes: a meta-research of meta-analysis studies
Xi Chen, Li‐Jun Yan, Jie Yang, et al.
Frontiers in Nutrition (2025) Vol. 12
Open Access
Vitamin D and Dapagliflozin Alleviate Renal Injury and Insulin Resistance in a Diet‐Induced Metabolic Syndrome Rat Model
Xincai Hong, Yongbin Ma, Weihong Yang, et al.
Journal of Biochemical and Molecular Toxicology (2025) Vol. 39, Iss. 3
Closed Access
Page 1 - Next Page

Scroll to top